tbuckley/cabot-search huggingface dataset:
PROGNOSIS OF CARDIAC SARCOIDOSIS PATIENTS USING BMIPP-SPECT AND CMR-LGE
Authors: Atsushi Yamamoto, Michinobu Nagao, Kenji Fukushima, Risako Nakao, Akiko Sakai, Eri Watanabe, Mitsuru Momose, Nobuhisa Hagiwara
Journal: Journal of the American College of Cardiology (2022)
Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT
Authors: Liu Xiao, Yuhao Li, Lin Li
Journal: Clinical Nuclear Medicine (2022)

Abstract Malignant peripheral nerve sheath tumors (MPNSTs) of bone are rare. It is mainly located in the appendicular skeleton. The lung is the most common site of metastasis. Solitary lymph node metastasis is very rare. Herein, we report the imaging findings of MPNST in the first thoracic vertebra with lymph node metastasis in the left axillary region. On FDG PET/CT, these lesions had intense FDG uptake. This case highlights that solitary lytic thoracic vertebral lesion with intense FDG accumulation should regard MPNST as a differential diagnosis and that FDG PET/CT has an important role in the initial staging of MPNST.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Authors: Olive S. Eckstein, Carl E. Allen, P. Mickey Williams, Sinchita Roy-Chowdhuri, David R. Patton, Brent Coffey, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo, Stacey L. Berg, Nilsa C. Ramirez, Alok Jaju, Joyce Mhlanga, Elizabeth Fox, Douglas S. Hawkins, Margaret M. Mooney, Naoko Takebe, James V. Tricoli, Katherine A. Janeway, Nita L. Seibel, D. Williams Parsons
Journal: Journal of Clinical Oncology (2022)

The NCI-COG Pediatric MATCH trial assigns patients age 1-21 years with relapsed or refractory solid tumors, lymphomas, and histiocytic disorders to phase II studies of molecularly targeted therapies on the basis of detection of predefined genetic alterations. Patients with tumors harboring mutations or fusions driving activation of the mitogen-activated protein kinase (MAPK) pathway were treated with the MEK inhibitor selumetinib.
Visit-to-visit blood pressure variability and the risk of stroke in the Netherlands: A population-based cohort study
Authors: Alis Heshmatollah, Yuan Ma, Lana Fani, Peter J. Koudstaal, M. Arfan Ikram, M. Kamran Ikram
Journal: PLoS Medicine (2022)

Apart from blood pressure level itself, variation in blood pressure has been implicated in the development of stroke in subgroups at high cardiovascular risk. We determined the association between visit-to-visit blood pressure variability and stroke risk in the general population, taking into account the size and direction of variation and several time intervals prior to stroke diagnosis.From 1990 to 2016, we included 9,958 stroke-free participants of the population-based Rotterdam Study in the Netherlands. This is a prospective cohort study including participants aged 45 years and older. Systolic blood pressure (SBP) variability was calculated as absolute SBP difference divided by mean SBP over 2 sequential visits (median 4.6 years apart). Directional SBP variability was defined as SBP difference over 2 visits divided by mean SBP. Using time-varying Cox proportional hazards models adjusted for age, sex, mean SBP, and cardiovascular risk factors, hazard ratios (HRs) for stroke up to January 2016 were estimated per SD increase and in tertiles of variability. We also conducted analyses with 3-, 6-, and 9-year intervals between variability measurement and stroke assessment. These analyses were repeated for diastolic blood pressure (DBP). The mean age of the study population was 67.4 ± 8.2 years and 5,776 (58.0%) were women. During a median follow-up of 10.1 years, 971 (9.8%) participants had a stroke, including 641 ischemic, 89 hemorrhagic, and 241 unspecified strokes. SBP variability was associated with an increased risk of hemorrhagic stroke (HR per SD 1.27, 95% CI 1.05-1.54, p = 0.02) and unspecified stroke (HR per SD 1.21, 95% CI 1.09-1.34, p < 0.001). The associations were stronger for all stroke subtypes with longer time intervals; the HR for any stroke was 1.29 (95% CI 1.21-1.36, p < 0.001) at 3 years, 1.47 (95% CI 1.35-1.59, p < 0.001) at 6 years, and 1.38 (95%CI 1.24-1.51, p < 0.001) at 9 years. For DBP variability, we found an association with unspecified stroke risk. Both the rise and fall of SBP and the fall of DBP were associated with an increased risk for unspecified stroke. Limitations of the study include that, due to an average interval of 4 years between visits, our findings may not be generalizable to blood pressure variability over shorter periods.In this population-based study, we found that visit-to-visit blood pressure variation was associated with an increased risk of unspecified and hemorrhagic stroke, independent of direction of variation or mean blood pressure.
Novel method to remove deeply migrated pancreatic duct stent
Authors: Wee Khoon Ng, Quan Rui Tan, Sundeep Jaywantraj Punamiya, Paul Jau Lueng Ong, Charles Kien Fong Vu
Journal: Endoscopy (2022)

Many techniques have been described for the removal of proximally migrated pancreatic duct (PD) stents, with a reported success rate of 80 % [1]. Success depends on the location of the stent and caliber of PD. In general, it is more difficult if the PD is narrow or not dilated and the stent in located in the pancreatic tail.
INCREASED ATRIAL FIBROSIS AND ARRHYTHMIA RECURRENCE IN ATRIAL FIBRILLATION PATIENTS WITH CORONARY ARTERY DISEASE
Authors: Mario Mekhael, Abdel Hadi El Hajjar, Charbel Noujaim, Jaspreet Thind, Yichi Zhang, Tarek Hassan Ayoub, Christopher Pottle, Chao Huang, Lilas Dagher, Chan Ho Lim, Alan Morris, Eugene G. Kholmovski, Nassir F. Marrouche
Journal: Journal of the American College of Cardiology (2022)
HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
Authors: Aayush Visaria, Stephanie Hong, Priyal Makwana, Sijin Wen, Scott Chapman, Maryam Khodaverdi, Jasvinder Singh, Oluwabunmi Ogungbe, Jacob Neumann, Sula Mazimba, George G. Sokos, Brijesh D. Patel
Journal: Journal of the American College of Cardiology (2022)
BIOPROSTHETIC LEAFLET THROMBOSIS AFTER TRANSCATHETER MITRAL VALVE-IN-VALVE IMPLANTATION
Authors: Lindsey Kuohn, Cezar Staniloae, Hasan Jilaihawi, Homam Ibrahim, Daniel Bamira, Illya Pushkar, Alan Vainrib, Richard Ro, Mathew Williams, Muhamed Saric
Journal: Journal of the American College of Cardiology (2022)
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
Authors: Xiaofei Wang, Xiangyu Chen, Jiaxing Tan, Shuai Yue, Runhong Zhou, Yan Xu, Yao Lin, Yang Yang, Yan Zhou, Kai Deng, Zhiwei Chen, Lilin Ye, Yongqun Zhu
Journal: Cell Host & Microbe (2022)
Incident Cardiovascular Disease Among Adults With Cancer
Authors: D. Ian Paterson, Natasha Wiebe, Winson Y. Cheung, John R. Mackey, Edith Pituskin, Anthony Reiman, Marcello Tonelli
Journal: JACC CardioOncology (2022)

Patients with cancer and cancer survivors are at increased risk for incident heart failure, but there are conflicting data on the long-term risk for other cardiovascular events and how such risk may vary by cancer site.The aim of this study was to determine the impact of a new cancer diagnosis on the risk for fatal and nonfatal cardiovascular events.Using administrative health care databases, a population-based retrospective cohort study was conducted among 4,519,243 adults residing in Alberta, Canada, from April 2007 to December 2018. Participants with new cancer diagnoses during the study period were compared with those without cancer with respect to risk for subsequent cardiovascular events (cardiovascular mortality, myocardial infarction, stroke, heart failure, and pulmonary embolism) using time-to-event survival models after adjusting for sociodemographic data and comorbidities.A total of 224,016 participants with new cancer diagnoses were identified, as well as 73,360 cardiovascular deaths and 470,481 nonfatal cardiovascular events during a median follow-up period of 11.8 years. After adjustment, participants with cancer had HRs of 1.33 (95% CI: 1.29-1.37) for cardiovascular mortality, 1.01 (95% CI: 0.97-1.05) for myocardial infarction, 1.44 (95% CI: 1.41-1.47) for stroke, 1.62 (95% CI: 1.59-1.65) for heart failure, and 3.43 (95% CI: 3.37-3.50) for pulmonary embolism, compared with participants without cancer. Cardiovascular risk was highest for patients with genitourinary, gastrointestinal, thoracic, nervous system and hematologic malignancies.A new cancer diagnosis is independently associated with a significantly increased risk for cardiovascular death and nonfatal morbidity regardless of cancer site. These findings highlight the need for a collaborative approach to health care for patients with cancer and cancer survivors.
SEX DIFFERENCES IN FUTURE HYPERTENSION CAUSED BY INCREASED ABDOMINAL CIRCUMFERENCE IN MILDLY OBESE MIDDLE-AGED PARTICIPANTS
Authors: Yuichi Ninomiya, Shin Kawasoe, Takuro Kubozono, Akihiro Tokushige, Hitoshi Ichiki, Yoshiyuki Ikeda, Hironori Miyahara, Koichi Tokushige, Mitsuru Ohishi
Journal: Journal of the American College of Cardiology (2022)
Causal analysis as a bridge between qualitative and quantitative research
Authors: Rosemary Blersch, Neil Franchuk, Miranda Lucas, Christina M. Nord, Stephanie Varsanyi, Tyler R. Bonnell
Journal: Behavioral and Brain Sciences (2022)

Yarkoni argues that one solution is to abandon quantitative methods for qualitative ones. While we agree that qualitative methods are undervalued, we argue that both are necessary for thoroughgoing psychological research, complementing one another through the use of causal analysis. We illustrate how directed acyclic graphs can bridge qualitative and quantitative methods, thereby fostering understanding between different psychological methodologies.
ECG-AI: AN EXTERNALLY VALIDATED DEEP LEARNING MODEL TO PREDICT HEART FAILURE RISK
Authors: Oguz Akbilgic, Liam Butler, Ibrahim Karabayir, Dalane W. Kitzman, Gari Clifford, Lin Yee Chen, Alvaro Alonso, Patricia P. Chang, Elsayed Z. Soliman
Journal: Journal of the American College of Cardiology (2022)
CLO22-046: A Prospective Study Comparing Acute Toxicities With Three Dimensional Conformal Radiation Therapy versus Intensity Modulated Radiation Therapy in Carcinoma Cervix Patients at a Tertiary Cancer Center
Authors: Syeda Tahera Fatima
Journal: Journal of the National Comprehensive Cancer Network (2022)

"CLO22-046: A Prospective Study Comparing Acute Toxicities With Three Dimensional Conformal Radiation Therapy versus Intensity Modulated Radiation Therapy in Carcinoma Cervix Patients at a Tertiary Cancer Center" published on 31 Mar 2022 by National Comprehensive Cancer Network.
Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Child Growth Trajectories in the First Two Years
Authors: Yu Gao, Jiajun Luo, Yan Zhang, Chengyu Pan, Yunjie Ren, Jun Zhang, Ying Tian
Journal: Environmental Health Perspectives (2022)

Background: Pregnant women are ubiquitously exposed to per- and polyfluoroalkyl substances (PFAS). Prenatal exposure to PFAS has been associated with lower birth weight but also with excess adiposity and higher weight in childhood. These mixed findings warrant investigation of the relationship between PFAS and dynamic offspring growth. Objectives: To investigate the association between prenatal PFAS exposure and early-life growth trajectories during the first 2 y. Methods: Pregnant women (n=3,426) were recruited from 2013 to 2016 from the Shanghai Birth Cohort (SBC) Study, and their children were followed up from birth to 2 y of age. Seven PFAS congeners were quantified in pregnant women’s serum during the first trimester. Our study population was restricted to 1,350 children who had five repeated measurements for at least one anthropometric measure. Four anthropometric measures, including weight, length/height, weight-for-length, and head circumference, were evaluated at birth, 42 d, 6 months, 12 months, and 24 months, and standardized into z-scores using the World Health Organization reference. Trajectories of each measure were classified into five groups using group-based trajectory modeling. Multinomial logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (CI) for trajectory groups according to log2-transformed PFAS concentrations, and the moderate-stable group was selected as the reference group for all measures. Results: Higher prenatal exposure to PFAS was associated with elevated odds for the low-rising weight-for-age z-score (WAZ) trajectory, and the high-rising length-for-age z-score (LAZ) trajectory. Meanwhile, PFAS levels were associated with decreased odds for the low-rising and high-rising weight-for-length z-score (WLZ) trajectories. In addition, the associations of PFAS with growth trajectory groups differed by sex, where males had greater odds for the low-rising and low-stable WAZ trajectories and for the high-stable and low-rising WLZ trajectories. In contrast, inverse associations were consistently observed with trajectories of the high-stable, low-stable, and low-rising head-circumference-for-age z-score (HCZ) in relation to most individual PFAS congeners. PFAS mixtures analysis further confirmed the above findings. Discussion: Trajectory analysis approach provided insight into the complex associations between PFAS exposure and offspring growth. Future studies are warranted to confirm the present findings with trajectory modeling strategies and understand the clinical significance of these trajectory groups. https://doi.org/10.1289/EHP9875
ZEB1 transcription factor promotes immune escape in melanoma
Authors: Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon, Jonathan Lopez, Myrtille Le-Bouar, Brigitte Balme, Garance Tondeur, Arnaud de la Fouchardière, Lionel Larue, Alain Puisieux, Yenkel Grinberg-Bleyer, Nathalie Bendriss-Vermare, Bertrand Dubois, Christophe Caux, Stéphane Dalle, Julie Caramel
Journal: Journal for ImmunoTherapy of Cancer (2022)

Background The efficacy of immunotherapies in metastatic melanoma depends on a robust T cell infiltration. Oncogenic alterations of tumor cells have been associated to T cell exclusion. Identifying novel cancer cell-intrinsic non-genetic mechanisms of immune escape, the targeting of which would reinstate T cell recruitment, would allow to restore the response to anti-programmed cell death protein 1 (PD-1) antibody therapy. The epithelial-to-mesenchymal transition (EMT)-inducing transcription factor ZEB1 is a major regulator of melanoma cell plasticity, driving resistance to mitogen-activated protein kinase (MAPK) targeted therapies. We thus wondered whether ZEB1 signaling in melanoma cells may promote immune evasion and resistance to immunotherapy. Methods We evaluated the putative correlation between ZEB1 expression in melanoma cells and the composition of the immune infiltrate in a cohort of 60 human melanoma samples by combining transcriptomic (RNA-sequencing) and seven-color spatial multi-immunofluorescence analyses. Algorithm-based spatial reconstitution of tumors allowed the quantification of CD8 + , CD4 + T cells number and their activation state (PD-1, Ki67). ZEB1 gain-of-function or loss-of-function approaches were then implemented in syngeneic melanoma mouse models, followed by monitoring of tumor growth, quantification of immune cell populations frequency and function by flow cytometry, cytokines secretion by multiplex analyses. Chromatin-immunoprecipitation was used to demonstrate the direct binding of this transcription factor on the promoters of cytokine-encoding genes. Finally, the sensitivity to anti-PD-1 antibody therapy upon ZEB1 gain-of-function or loss-of-function was evaluated. Results Combined spatial and transcriptomic analyses of the immune infiltrates in human melanoma samples demonstrated that ZEB1 expression in melanoma cells is associated with decreased CD8 + T cell infiltration, independently of β-catenin pathway activation. ZEB1 ectopic expression in melanoma cells impairs CD8 + T cell recruitment in syngeneic mouse models, resulting in tumor immune evasion and resistance to immune checkpoint blockade. Mechanistically, we demonstrate that ZEB1 directly represses the secretion of T cell-attracting chemokines, including CXCL10. Finally, Zeb1 knock-out, by promoting CD8 + T cell infiltration, synergizes with anti-PD-1 antibody therapy in promoting tumor regression. Conclusions We identify the ZEB1 transcription factor as a key determinant of melanoma immune escape, highlighting a previously unknown therapeutic target to increase efficacy of immunotherapy in melanoma. Trial registration number NCT02828202 .
Lower respiratory tract infections in children requiring mechanical ventilation: a multicentre prospective surveillance study incorporating airway metagenomics
Authors: Alexandra Tsitsiklis, Christina M Osborne, Jack Kamm, Kayla Williamson, Katrina Kalantar, Gytis Dudas, Saharai Caldera, Amy Lyden, Michelle Tan, Norma Neff, Victoria Soesanto, J Kirk Harris, Lilliam Ambroggio, Aline B Maddux, Todd C Carpenter, Ron W Reeder, Chris Locandro, Eric A F Simões, Matthew K Leroue, Mark W Hall, Athena F Zuppa, Joseph Carcillo, Kathleen L Meert, Anil Sapru, Murray M Pollack, Patrick S McQuillen, Daniel A Notterman, J Michael Dean, Matt S Zinter, Brandie D Wagner, Joseph L DeRisi, Peter M Mourani, Charles R Langelier
Journal: The Lancet Microbe (2022)

Lower respiratory tract infections (LRTI) are a leading cause of critical illness and mortality in mechanically ventilated children; however, the pathogenic microbes frequently remain unknown. We combined traditional diagnostics with metagenomic next generation sequencing (mNGS) to evaluate the cause of LRTI in critically ill children.We conducted a prospective, multicentre cohort study of critically ill children aged 31 days to 17 years with respiratory failure requiring mechanical ventilation (>72 h) in the USA. By combining bacterial culture and upper respiratory viral PCR testing with mNGS of tracheal aspirate collected from all patients within 24 h of intubation, we determined the prevalence, age distribution, and seasonal variation of viral and bacterial respiratory pathogens detected by either method in children with or without LRTI.Between Feb 26, 2015, and Dec 31, 2017, of the 514 enrolled patients, 397 were eligible and included in the study (276 children with LRTI and 121 with no evidence of LRTI). A presumptive microbiological cause was identified in 255 (92%) children with LRTI, with respiratory syncytial virus (127 [46%]), Haemophilus influenzae (70 [25%]), and Moraxella catarrhalis (65 [24%]) being most prevalent. mNGS identified uncommon pathogens including Ureaplasma parvum and Bocavirus. Co-detection of viral and bacterial pathogens occurred in 144 (52%) patients. Incidental carriage of potentially pathogenic microbes occurred in 82 (68%) children without LRTI, with rhinovirus (30 [25%]) being most prevalent. Respiratory syncytial virus (p<0·0001), H influenzae (p=0·0006), and M catarrhalis (p=0·0002) were most common in children younger than 5 years. Viral and bacterial LRTI occurred predominantly during winter months.These findings demonstrate that respiratory syncytial virus, H influenzae, and M catarrhalis contribute disproportionately to severe paediatric LRTI, co-infections are common, and incidental carriage of potentially pathogenic microbes occurs frequently. Further, we provide a framework for future epidemiological and emerging pathogen surveillance studies, highlighting the potential for metagenomics to enhance clinical diagnosis.US National Institutes of Health and CZ Biohub.
SOCIODEMOGRAPHIC, CLINICAL, AND HEALTH CARE CHARACTERISTICS ASSOCIATED WITH CARDIAC REHABILITATION REFERRAL AND ENROLLMENT IN AN ACADEMIC MEDICAL CENTER
Authors: Lena Mathews, Ashley Broderick, Alex Bush, Kerry J. Stewart, Roger S. Blumenthal, Rachel L.J. Thornton, Kunihiro Matsushita, Chiadi E. Ndumele
Journal: Journal of the American College of Cardiology (2022)
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
Authors: Christopher L. Bowlus, Michael R. Galambos, Richard J. Aspinall, Gideon M. Hirschfield, David E.J. Jones, Yvonne Dörffel, Stuart C. Gordon, Stephen A. Harrison, Andreas E. Kremer, Marlyn J. Mayo, Paul J. Thuluvath, Cynthia Levy, Mark G. Swain, Guy W. Neff, David A. Sheridan, Carmen M. Stanca, Christoph P. Berg, Aparna Goel, Mitchell L. Shiffman, John M. Vierling, Pol Boudes, Alexandra Steinberg, Yun-Jung Choi, Charles A. McWherter
Journal: Journal of Hepatology (2022)
CHALLENGES FACING HEART FAILURE PATIENTS WITH LIMITED ENGLISH PROFICIENCY: A QUALITATIVE ANALYSIS LEVERAGING MEDICAL INTERPRETERS’ PERSPECTIVES
Authors: Zara Latif, Tracy Makuvire, Shelli Leore Feder, Arthur R. Garan, Pablo Quintero Pinzon, Haider Javed Warraich
Journal: Journal of the American College of Cardiology (2022)
Error in Abstract
Journal: JAMA Psychiatry (2022)

Thomas Santo Jr, MPH; Brodie Clark, BPsych; Matt Hickman, PhD; Jason Grebely, PhD; Gabrielle Campbell, PhD; Luis Sordo, MD, PhD; Aileen Chen, BPsych; Lucy Thi Tran, BPsychSc; Chrianna Bharat, BSc; Prianka Padmanathan, MRCPsych; Grainne Cousins, PhD; Julie Dupouy, MD, PhD; Erin Kelty, PhD; Roberto Muga, MD, PhD; Bohdan Nosyk, PhD; Jeong Min, MSc; Raimondo Pavarin, MPH; Michael Farrell, MD; Louisa Degenhardt, PhD
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
Authors: Tao Xia, Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas, Hao Jing, Kenji Fujiwara, Haijie Hu, Arsen Osipov, Chunhui Yuan, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Jin He, Yiping Mou, Adrian G. Murphy, Lei Zheng
Journal: Journal of Hematology & Oncology (2022)

Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which is poorly understood.
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
Authors: Jennifer R. Kramer, Peter A. Richardson, Hyunseok Kim, Yao-Chun Hsu, Fasiha Kanwal, Hashem B. El-Serag
Journal: Clinical Gastroenterology and Hepatology (2022)
High-Volume Prescribers Drive Antibiotic Use in Medicare Part D
Authors: Bridget M. Kuehn
Journal: JAMA (2022)

The top 10% of antibiotic prescribers were responsible for 41% of antibiotic prescriptions for Medicare Part D beneficiaries in 2019, according to data from the Centers for Medicare &amp; Medicaid Services (CMS) Part D Prescriber Public Use Files.
TRANS-VALVULAR UNLOADING REDUCES ANAEROBIC GLYCOLYSIS BEFORE REPERFUSION AND PRESERVES ENERGY SUBSTRATE UTILIZATION AFTER REPERFUSION IN MODELS OF ACUTE MYOCARDIAL INFARCTION
Authors: Lija Swain, Xiaoying Qiao, Kay Everett, Shreyas Bhave, Lara Reyelt, Tejasvi Aryaputra, William Surks, Siya Goel, Elric Zweck, Nikolaos Diakos, Navin Kapur
Journal: Journal of the American College of Cardiology (2022)
EFFICACY OF THE NEW CALPAIN INHIBITOR NPO-2270 COMPARED WITH ENALAPRIL IN MOUSE MODELS OF HEART FAILURE
Authors: Javier Inserte, David Aluja Gonzalez, Sara Delgado Tomás, Jesus Llenas, Enrique Vazquez Tatay, Jose A. Barrabes, Ignacio Ferreira-Gonzalez
Journal: Journal of the American College of Cardiology (2022)
The calcium-sensing receptor stabilizes podocyte function in proteinuric humans and mice
Authors: Anne K. Mühlig, Johanna Steingröver, Hannah S. Heidelbach, Madelaine Wingerath, Wiebke Sachs, Irm Hermans-Borgmeyer, Catherine Meyer-Schwesinger, Hoon Young Choi, Beom Jin Lim, Christian Patry, Georg Friedrich Hoffmann, Nicole Endlich, Katharina Bracke, Mariella Weiß, Andreas H. Guse, Moritz Lassé, Markus M. Rinschen, Fabian Braun, Tobias B. Huber, Victor G. Puelles, Claus Peter Schmitt, Jun Oh
Journal: Kidney International (2022)